We studied the effects of vitamin A deficiency and repletion on rat insulin release and islet cellular retinol binding protein (CRBP) 
Introduction
Vitamin A deficiency is a world health problem leading to poor growth, blindness, and reproductive failure (1) . At the cellular level, vitamin A deficiency leads to abnormalities in cellular differentiation, glycoprotein synthesis, cell-to-cell adhesion, and changes in a wide variety of other membrane functions (2, 3) . These membrane functions are universal to cell biology and are potentially important in secretory cells. With the exception of its role in the visual cycle (4), the molecular mechanisms responsible for vitamin A function are not yet well defined. Recent studies suggest that retinoids affect gene expression in target cells. Retinol and retinoic acid bind to specific intracellular binding proteins, cellular retinol binding protein (CRBP)' and cellular retinoic acid binding protein (CRABP), respectively. Although the functions of these binding proteins are not known, it has been suggested that they might transport the retinoid to, or fa-cilitate its action in the nucleus to affect gene expression (similar to steroid hormones) (5) . In addition, retinol binding protein (RBP), a specific plasma binding protein, circulates in plasma. Plasma RBP is synthesized in the liver and serves to mobilize retinol from the liver. When released into the circulation, retinol-RBP complexes with transthyretin (TTR, more commonly known as prealbumin) and circulates normally in a one-to-one molar ratio (retinol-RBP-TTR [6] ).
Recent studies (7) have demonstrated the presence of relatively high levels ofCRBP, CRABP, TTR, and RBP in pancreatic rat islets. We have also shown that retinoids influence islet insulin secretion, ultrastructure and cell aggregation (8) (9) (10) . These findings suggest that retinoids and their binding proteins may have an important role in islet function. To test for a functional role of vitamin A, we studied the effects of the retinol and retinoic acid deficiency on insulin secretion. We also determined whether retinol or retinoic acid deficiency had effects on the islet concentrations of cellular retinoid binding proteins which, in turn, might modulate vitamin A action.
Methods
Vitamin A deficiency model and insulin secretion. Two potential problems exist in models ofvitamin A-deficiency: (a) Rats may not synchronously develop complete vitamin A deficiency, and (b) vitamin A-deficient rats have decreased food intake and growth which may affect insulin secretion (1 1) . To assure a complete deficiency of retinol and retinoic acid and to minimize the variables of decreased food intake on insulin release, we adapted the model ofOlson et al., (12) (13) (14) with modifications. The model calls for cycles of rapid synchronously induced vitamin A deficiency while avoiding generalized nutritional deficiency. In this model, vitamin A-deficient rats are repeatedly cycled with dietary all trans-retinoic acid.
Because all trans-retinoic acid is not stored in the liver and is rapidly metabolized and excreted, discontinuation of all trans-retinoic acid rapidly leads to vitamin A deficiency. In initial studies using commercially obtained rats, we (17, 18) . First or second phase or cumulative insulin release was determined by calculating the area under the curve for each phase.
At the same time that the pancreases were removed, samples of blood were obtained for vitamin A assay (19) . Serum retinol was found to be <2 gg/dl validating the vitamin A-deficient state.
Islet CRBP and CRABP. Islets were isolated from groups of normal and repleted vitamin A-deficient rats. Approximately 300 to 1,000 islets from three to five rats in each group (n = 1) were washed three to five times in phosphate-buffered saline pH 7.4 (PBS) and then rapidly frozen and stored until used for radioimmunoassay. Islets were then thawed and homogenized in 1 ml of assay buffer containing 50 mM imidazole buffer pH 7.4,0.79% NaCl, 0.03% bovine serum albumin, 0.1I% thiomerosal, 0.0 1% leupeptin, and 1.0% Triton X-1I00. CRBP and CRABP levels were determined by recently developed sensitive and specific radioimmunoassays for each protein (7, 20 Islet insulin and protein content. Islets were isolated from groups of normal, A-deficient, and retinoic acid-and retinyl palmitate-repleted rats. For measurement of insulin, islets were isolated from each rat digest (n = 1) and washed in buffer. 2-20 batches of 10 islets from each rat digest were added to 1.0 ml of acid ethanol, sonicated. for 1 min, microcentrifuged, and the extract assayed for insulin (n = 1). For measurement of protein content, '-300-1000 islets were isolated from three to five rats and homogenized, and the protein content of homogenate (n = 1) measured by the method of Bradford (21) .
In vivo glucose tolerance and insulin secretion. Normal, vitamin Adeficient, and retinoic acid-and retinyl palmitate-repleted rats had an intravenous glucose tolerance test after an overnight 16-h fast. Normal rats, weighing 300-400 g, were not made vitamin A-deficient, were on a synthetic diet and received retinyl palmitate, 6.6-,ug/g diet. Vitamin
A-deficient and repleted rats were prepared as described above for studies in vitro. To assure injection of the total glucose bolus and adequate sample volume without hemolysis (which interferes with our insulin assay), studies measuring insulin release and glucose tolerance were performed separately; rats were anesthetized with ketamine hydrochloride (Bristol Laboratories, Syracuse, NY), 100 mg/kg i.m.; glucose, 1 g/kg, was injected incardiacally and blood was aspirated from the heart with a 2 1-gauge needle. Blood for glucose was drawn at 0, 15, 30 , and 60 min, and blood for insulin was drawn at 0 and 1.0 mmn after injection. Blood was collected in microcentrifuge tubes, immediately centrifuged, and the plasma frozen for assay of insulin by radioimmunoassay and serum frozen for glucose by the glucose oxidase method using a glucose analyzer 2 (Beckman Instruments, Inc., Fullerton, CA) at a later date (22 (23, 24) .
Morphological studies. Pancreases of 55-d-old male rats from one rat chow control, five vitamin A-deficient rats at weight plateau for 14-20 d, and one retinol-repleted rat, which was pair fed to the vitamin Adeficient rats, were fixed in Bouin's solution, dehydrated in graded ethanols, embedded in paraffin and cut into 5-Mm thick sections. In each pancreas, at least two series of four consecutive sections (the series were cut throughout the gland at 200 mP distance) were processed for indirect immunofluorescence using the following antisera and dilutions: (a) guinea pig anti-insulin (Dr. 
Results
Effects ofvitamin A deficiency on food intake, body weight and insulin secretion in vitro. Rats placed on a vitamin A-deficient diet for 14 d during the test period ate the same amount offood, but continued to show a weight plateau, with a mean weight gain of 8.9±4.1 g (Table I ). Both phases of insulin release from islets of vitamin A-deficient rats were markedly impaired (Fig. 2) .
Effects ofalltrans-retinoic acid and retinylpalmitate repletion on body weight, food intake, and insulin secretion in vitro. The effects of repletion of vitamin A-deficient rats during the 14-d test period with either all trans-retinoic aicd, 2-Ag/g diet or retinyl palmitate, 4-,gg/g diet, are shown in Table I. There were no significant differences in food intake or weights between rats treated with retinoic acid, 2 gg/g and rats treated with retinyl palmitate, 4 ,g/g diet (Table I) . Figure 3 . The effects of RP, 4 s/g diet, and RA repletion, 2 ,ug/g diet, on glucose-induced biphasic insulin release. The rats were bred and treated as above with the exception that the retinoate cycle started at day 75 of vitamin A deficiency (as in Fig. 1 tration ofprotein and insulin in islets (Table II) . The insulin and protein contents of islets were not statistically different between normal, vitamin A-deficient or repleted vitamin A-deficient rats. Effects of vitamin A deficiency and repletion on glucose tolerance and insulin secretion in vivo. Plasma insulins and serum glucose at zero time were not significantly different between groups (Fig. 6) . After glucose injection, mean serum glucoses were more variable and higher in vitamin A-deficient and repleted groups throughout the study compared to normal rats. 15 min after the glucose injection, the serum glucose was higher in vitamin A-deficient rats than in control rats (Fig. 7) (P < 0.05). Also at 15 min, the serum glucoses in rats repleted with retinoic acid or retinyl palmitate were lower than the serum glucose of vitamin A-deficient rats (P < 0.05). The peak plasma insulin one minute after glucose injection was decreased in vitamin A- except that the dose of RA was increased to 8 jsg/g diet during the test period. Secretion from islets of RA-treated rats was not significantly different from islets of RP-treated rats except at 10 min. deficient rats (Fig. 7) (P < 0.01). Compared to vitamin A-deficient rats, retinyl palmitate repletion, but not retinoic acid repletion, significantly increased peak plasma insulin (P < 0.02).
Effects of vitamin A deficiency on pancreatic morphology.
The islets appeared normal in size, number and structure by conventional light microscopy ( Fig. 8, A) . Observations of at least 30 islets per pancreas (n = 5) after immunostaining for the four main islet hormones failed to reveal obvious changes in the topographical and numerical relationships of the main islet cell types. As in controls, the insulin-containing B cells were thus the preponderant cell type in the islets ofthe vitamin A-deficient rats and formed the major part of their cores (Fig. 8, 1B ). The glucagon-containing A cells (Fig. 8, C) , the somatostatin-containing D cells and the pancreatic polypeptide-containing cells were less numerous and were intermixed at the periphery of the islets. (In preliminary studies, on conventional microscopy, pancreases from vitamin A-deficient cycled rats had changes in the exocrine pancreas. Detailed morphological and functional studies of the exocrine pancreas are planned and will be reported separately.) No obvious structural alteration was detected in the pancreas of one vitamin A-deficient rat that was pair fed a retinol-repleted diet.
Discussion
Our results indicate that insulin release in vitro from islets of vitamin A-deficient rats is markedly impaired in response to (4) 808±88 (8) A-deficiency 180±20 (4) 820±67 (7) Retinoic acid 2 ug/g 210±80 (3) 796-218 (5) Retinyl palmitate 4 jg/g 160±50 (4) 905±286 (4) The islet concentrations of protein and insulin were not significantly different between groups. Values in parentheses are the number of batches of islets studied. substitute for retinyl palmitate, indicating that the impairment of insulin release in vitro was a result of retinol deficiency and not due to decreased food intake and impaired growth. One possible explanation for the impairment of insulin secretion is that vitamin A deficiency results in a change in the quality of pancreatic tissue which could conceivably increase collagenase digestion of the pancreas and islets, and in turn, impair islet function, This does not appear to be the case. The pancreases of vitamin A-deficient rats and rats treated with retinoic acid, 2 ug/g, were not different from control pancreases of rats repleted with retinyl palmitate, 4 ,ug/g, or retinoic acid, 8 Ag/g. Yet, islets from vitamin A-deficient and 2-,g/g retinoic acid-treated rats secreted less insulin. Further, our in vivo data support our in vitro findings. In vivo, vitamin A-deficient rats demonstrated impairment ofacute insulin release and impaired glucose tolerance at 15 min, indicating that a defect in insulin release is evident prior to islet preparation. This defect in insulin release was reversed by retinyl palmitate repletion but not retinoic acid repletion. The in vivo findings support the conclusion that the in vitro defect is related to a specific action of vitamin A and its deficiency in vivo.
Whereas a defect in insulin release was observed in vitamin A-deficient rats both in vivo and in vitro, and this defect was improved with retinyl palmitate repletion but not with retinoic acid repletion, both retinyl palmitate-and retinoic acid-repleted rats showed improved glucose tolerance compared with A-deficient rats. The improvement in glucose tolerance in retinoic acid-repleted rats may be related to decreases in activity of the sympathetic nervous system (25) or other glucose counterregulatory hormones upon repletion. The lack of a difference in glucose tolerance between retinyl palmitate-repleted and retinoic acid-repleted rats may be due to the lack ofspecificity ofglucose tolerance testing for insulin secretion.
The mechanism by which vitamin A deficiency impairs insulin release remains to be determined. (2) . Deficiency of vitamin A could lead to impaired synthesis of proteins, either directly or indirectly related to microfilamentous function (26) , or membrane glycoproteins (2) . In epithelial cells, vitamin A is known to induce the synthesis of different keratins (27) (28) (29) . Although nothing is known about vitamin A-induced syntheses of mRNA and its gene products in islets, the identification of a 60-kD intermediate filamentous protein as an islet keratin (30) provides an exciting starting point to examine the possible regulatory effects ofvitamin A on islet mRNA and protein synthesis. This islet protein is associated with the cytoskeleton of the hamster insulinoma cell (31) and undergoes calciumand cyclic-AMP regulated phosphorylation by an islet protein kinase concomitant with insulin release (32) . If vitamin A regulates the synthesis of this keratin and this keratin is part of the islet cytoskeleton, a deficiency of vitamin A could lead to decreased keratin and, in turn, a defect in microfilament function and insulin release. Another possibility is that vitamin A regulates and induction ofislet transglutaminase, an enzyme that catalyzes the crosslinking ofproteins, possibly microfilamentous proteins. Vitamin A is known to alter the expression of tissue transglutaminase in epithelial cells (33) and leukemic cells (34) . Islet transglutaminase has been proposed to have a role in regulating the access of beta cell granules to exocytic sites (35) . If retinoids affect islet transglutaminase, then vitamin A may be involved in regulating the release of insulin granules.
Previous studies have demonstrated the presence of retinoid binding proteins in normal islets (7) . Whether retinoids also play a role in islet cell growth and differentiation in fetal and adult islets as in other cells, deserves further investigation because of the relevance to abnormal islet growth, diabetes mellitus, and islet transplantation. Preliminary data (36) indicating that CRBP is selectively concentrated in the anterior pituitary gland suggest that retinoids may be important in hormone secretion from other endocrine glands.
